Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy

被引:48
|
作者
Drazilova, Sylvia [1 ]
Gazda, Jakub [2 ,3 ]
Janicko, Martin [2 ,3 ]
Jarcuska, Peter [2 ,3 ]
机构
[1] Hosp Poprad, Dept Internal Med, Poprad, Slovakia
[2] Safarik Univ, Fac Med, Dept Internal Med 1, Kosice, Slovakia
[3] L Pasteur Univ Hosp, Kosice, Slovakia
关键词
SUSTAINED VIROLOGICAL RESPONSE; ACTING ANTIVIRAL AGENTS; SERUM-LIPID PROFILES; VIRUS-INFECTION; INSULIN-RESISTANCE; GLUCOSE ABNORMALITIES; INTERFERON-ALPHA; GLYCEMIC CONTROL; PLUS RIBAVIRIN; HCV INFECTION;
D O I
10.1155/2018/6150861
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with chronic hepatitis C have both higher prevalence of diabetes mellitus type 2 (T2DM) and increased cardiovascular risk compared to never infected people. Sustained viral response (SVR) achievement led to decreasing incidence and prevalence of T2DM during the interferon era of HCV treatment. Currently, direct-acting antiviral drugs (DAA) are the gold standard for treating HCV infection, while yielding SVR in nearly all patients. In chronic HCV patients with T2DM (prediabetes most likely too), DAA therapy is associated with both better fasting glucose and glycated hemoglobin (HbA1C) controls; thus reducing pharmacotherapy in a certain part of patients is possible. Papers mentioned in the review confirmed DAA role in both total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) increase. This alteration was accompanied by an increase in high-density lipoprotein cholesterol (HDL-C) and a decrease in triglycerides (TG) verified by most of the studies. However, the clinical significance of lipoprotein alterations caused by DAA therapy has not been explained yet. Moreover, DAA treatment of chronic hepatitis C improves hypertension control and atherosclerotic plaques. It is very likely that DAA therapeutic regimens will decrease both T2DM prevalence and cardiovascular risk in chronic hepatitis C patients; further research, however, is needed.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Proinflammatory Cytokines and Cardiovascular Risk in Patients with Diabetes Mellitus and Chronic Hepatitis C
    Dragut, Ramona Maria
    Rusu, Emilia
    Nan, Raluca
    Rusu, Florin
    Enache, Georgiana
    Popescu, Horatiu
    Posea, Mihaela
    Cursaru, Andrian
    Grosu, Larisa
    Radulian, Gabriela
    DIABETES, 2015, 64 : A128 - A128
  • [2] Association of diabetes mellitus and chronic hepatitis C virus infection
    Balik, I
    Yilmaz, N
    Turkcapar, N
    Yasa, H
    HEPATOLOGY, 1999, 30 (02) : 584 - 584
  • [3] Association of diabetes mellitus and chronic hepatitis C virus infection
    Mason, AL
    Lau, JYN
    Hoang, N
    Qian, KP
    Alexander, GJM
    Xu, LZ
    Guo, LS
    Jacob, S
    Regenstein, FG
    Zimmerman, R
    Everhart, JE
    Wasserfall, C
    Maclaren, NK
    Perrillo, RP
    HEPATOLOGY, 1999, 29 (02) : 328 - 333
  • [4] Association of hepatitis C and diabetes mellitus
    Knobler, H
    Schattner, A
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) : 141 - 141
  • [5] The association between chronic hepatitis C infection and cardiovascular risk
    Pateria, P.
    Jeffrey, G. P.
    MacQuillan, G.
    Speers, D.
    Ching, H.
    Chinnaratha, M. A.
    Watts, G. F.
    Adams, L. A.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (01) : 63 - 70
  • [6] Is chronic hepatitis C infection a risk factor for developing diabetes mellitus before and after interferon therapy
    Reda, El-Kholy Omayma Saad
    Adalat, Hegazy
    Fatma, Eid
    BIOCHIMICA CLINICA, 2006, 30 (03) : 190 - 197
  • [7] Association of hepatitis C and diabetes mellitus - In response
    Mehta, SH
    Sulkowski, MS
    Thomas, DL
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) : 142 - 142
  • [8] Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy
    Diego García-Compeán
    José Alberto González-González
    Fernando Javier Lavalle-González
    Emmanuel Irineo González-Moreno
    Jesús Zacarías Villarreal-Pérez
    Héctor J. Maldonado-Garza
    Digestive Diseases and Sciences, 2016, 61 : 371 - 380
  • [9] Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy
    Garcia-Compean, Diego
    Alberto Gonzalez-Gonzalez, Jose
    Javier Lavalle-Gonzalez, Fernando
    Irineo Gonzalez-Moreno, Emmanuel
    Zacarias Villarreal-Perez, Jesus
    Maldonado-Garza, Hector J.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (02) : 371 - 380
  • [10] Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C
    Petit, JM
    Bour, JB
    Galland-Jos, C
    Minello, A
    Verges, B
    Guiguet, M
    Brun, JM
    Hillon, P
    JOURNAL OF HEPATOLOGY, 2001, 35 (02) : 279 - 283